• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

PULMONARY FIBROSIS INDUCED BY ANTICANCER DRUGS-ITS MECHANISM AND PROPHYLAXIS

Research Project

Project/Area Number 07672049
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 病態科学系歯学(含放射線系歯学)
Research InstitutionKochi Medical School

Principal Investigator

YONEDA Kazunori  Kochi Medical School, Department of Oral Surgery, Associate Professor, 医学部, 助教授 (90182849)

Co-Investigator(Kenkyū-buntansha) UETA Eisaku  Kochi Medical School, Department of Oral Surgery, Research Associate, 附属病院, 助手 (10203431)
YAMAMOTO Tetsuya  Kochi Medical School, Department of Oral Surgery, Assistant Professor, 医学部・附属病院, 講師 (00200824)
Project Period (FY) 1995 – 1997
Keywordspeplomycin / Azeptin / pulmonary fibrosis / cytokine / NF-kappaB / superoxide / signal transduction / alpha-smooth muscle actin
Research Abstract

To prevent pulmonary fibrosis (PF) in cancer chemotherapy, we examined the mechanism of peplomycin (PLM)-induced PF and obtained following results.
1. Both in and ex vivo, PLM enhanced cytokine generation by lymphocytes, macrophages, neutrophils and fibroblasts (Fb).
2. In and ex vivo PLM enhanced proliferation and collagen synthesis of Fb.
3. In Fb, lymphocytes and neutrophils, PLM enhanced phosphorylation of inositols protein and tyrosine residues and activated^<ras> p21 and MAPK,inducing activation of NF-kappaB with c-myc expression.
4. PLM activated p47^<phox> and p67^<phox> (components of NADPH) and increased reactive oxygen generation by neutrophils and macrophages.
5. Azelastine hydrochloride (Azeptin, an anti-allergic drug) inhibited these PLM activities and suppressed PLM-induced pulmonary fibrosis in mice.
6. PLM-induced fibrosis begun in the periphery of the lung and advanced to the central region, especially around the bronchi. Immunohistochemically and electromicroscopically. Fb in the lung with fibrosis expressed vimentin, desmin and alpha-smooth muscle (alpha-SM) actin. The change of Fb to myofibroblasts was ascertained by in situ hybridization of alpha-SM and blotting for alpha-SM-mRNA and its protein.
These results indicate that PLM-induced fibrosis is resulted from enhanced signal transduction which induces cytokine and reactive oxygen generation, that Azeptin is expected to prohibit pulmonary fibrosis in cancer therapy and that with advance of fibrosis, Fb, become myofibroblasts expressing alpha-SM.Therefore, it is important to investigate the intracellular signals associated with the expression of alpha-SM.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Eisaku Ueta: "Contrasting influence of peplomycin and azelastine hydrochloride(Azeptin)on reactive oxygen generation in polymorphonuclear leukocytes,cytokine generation in lymphocytes,and collagen synthesis in fibroblasts" Cancer Chemotherapy & Pharmacology. 35. 230-236 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Eisaku Ueta: "Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative.peplomycin" Free Radical Research. 22. 533-544 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 米田 和典: "アゼプチン【○!R】によるブレオマイシン肺線維症の抑制" 日本癌治療学会誌. 31. 406-412 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kazunori Yoneda: "Suppression by azelastine hydrochloride of NF-kB activation involved in generation of cytokines and nitric oxide" Japanese Journal of Pharmacology. 73. 145-153 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kazunori Yoneda: "Azelastine hydrochloride(Azeptin)inhibits peplomycin(PLM)-induced pulmonary fibrosis by contradicting up-regulation of signal transduction" Anti-Cancer Drug Design. 12. 577-590 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Eisaku Ueta: "Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin)on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts" Cancer Chemotherapy & Pharmacology. 35 : 3. 230-236 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Eisaku Ueta: "Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycin" Free Radical Research. 22 : 6. 533-544 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kazunori Yoneda: "Inhibition of bleomycin-induced pulmonary fibrosis by Azeptin" The Journal of Japan Society for Cancer Therapy. 31 : 6. 406-412 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kazunori Yoneda: "Suppression by azelastine hydrochloride of NF-_KB activation involved in generation of cytokines and nitric oxide" Japanese Journal of Pharmacology. 73 : 2. 145-153 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kazunori Yoneda: "Azelastine hydrochloride (Azeptin) inhibits peplomycin (PLM)-induced pulmonary fibrosis by contradicting up-regulation of signal transduction" Anti-Cancer Drug Design. 12 : 7. 577-590 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi